<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01884012</url>
  </required_header>
  <id_info>
    <org_study_id>KEK 2012-0538</org_study_id>
    <nct_id>NCT01884012</nct_id>
  </id_info>
  <brief_title>Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized-controlled, cross-over trial the investigators test the effect of
      long-term oxygen therapy (&gt; 16h/day) given for 5 weeks with a wash-out period between phases
      of 2 weeks on exercise performance and quality of life and many physiological parameters in
      patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>5 weeks</time_frame>
    <description>6 minute walk distance according to american thoracic society (ATS) guidelines</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>5 weeks</time_frame>
    <description>QoL assessed by the short form of the medical outcome questionnaire (SF-36) physical functioning scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily activity</measure>
    <time_frame>5 week</time_frame>
    <description>measured by actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamics by echocardiography</measure>
    <time_frame>5 weeks</time_frame>
    <description>Full echocardiographic assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>5 weeks</time_frame>
    <description>SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>arterial blood gas</measure>
    <time_frame>5 weeks</time_frame>
    <description>partial pressure of oxygen (PaO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operating hours of oxygen concentrator</measure>
    <time_frame>5 weeks</time_frame>
    <description>efficacy of oxygen treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean nocturnal oxygen saturation</measure>
    <time_frame>5 weeks</time_frame>
    <description>Ambulatory Sleep Study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tests of cognitive performance</measure>
    <time_frame>5 weeks</time_frame>
    <description>STROOP-Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>5 weeks</time_frame>
    <description>Minnesota living with heart failure questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous blood</measure>
    <time_frame>5 weeks</time_frame>
    <description>N-terminal brain natriuretic peptide (NT-proBNP)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Supplemental oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplemental oxygen 3 liters/minute given via a nasal cannula for 16 hours a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham room air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Room air given at a flow rate of 3 liters per minute for 16 hours a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>long term oxygen therapy</intervention_name>
    <arm_group_label>Supplemental oxygen</arm_group_label>
    <arm_group_label>Sham room air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Adult patients with established diagnosis of pulmonary arterial or chronic thromboembolic
        pulmonary hypertension (class I and IV according to the latest WHO classification scheme of
        Dana Point 2008) on optimized medical therapy and in stable condition for at least 4 weeks,
        who desaturate in the 6 minute walking test by =4% to values &lt;92%.

        Exclusion criteria:

          -  Patients in unstable conditions requiring frequent therapeutic adaption

          -  pregnant women

          -  patients with pulmonary venous hypertension due to left heart diseases

          -  patients with relevant concomitant lung disease and severe daytime hypoxemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Ulrich Somaini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Pneumology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Pneumology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2013</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

